Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries

Bursa Postgraduate Hospital63 enrolled

Overview

The aim of this study was to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries.

In total, 18 patients (renal stent group) who underwent renal stent implantation in ectatic/aneurysmatic coronary arteries requiring percutaneous coronary intervention (PCI) and 45 patients who underwent large-sized bare metal coronary stent (BMCS) implantation (BMCS group) at our centre between 2015 and 2020 were included in the study. Control coronary angiography (CAG) was performed during the follow-up of these patients, and angiography-guided quantitative measurements were performed during PCI. The primary endpoints were myocardial infarction and cardiovascular mortality, and the secondary endpoints were restenosis and all-cause mortality.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Coronary Artery Ectasia

Interventions

Renal stentDRUG

renal stent implantation in ectatic/aneurysmatic coronary arteries

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Acute coronary syndrome patients * 18 year age * ectatic/aneurysmatic coronary arteries Exclusion Criteria: * Patients who underwent elective procedures, * experienced unsuccessful attempts * referred to surgical revascularization

Outcomes

Primary Outcomes

primary endpoints

Rate of myocardial infarction and cardiovascular mortality

Time frame: 2 year

Secondary Outcomes

secondary endpoints

Rate of restenosis and all-cause mortality

Time frame: 2 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.